73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
New insights into how blood pressure drug may benefit patients with locally advanced pancreatic cancer

New insights into how blood pressure drug may benefit patients with locally advanced pancreatic cancer

byMassachusetts General HospitalCredit: Unsplash/CC0 Public DomainPancreatic cancer is highly lethal, and surgical removal of tumor tissue is currently the only potential cure for most patients.

New insights into how blood pressure drug may benefit patients with locally advanced pancreatic cancer

byMassachusetts General HospitalCredit: Unsplash/CC0 Public DomainPancreatic cancer is highly lethal, and surgical removal of tumor tissue is currently the only potential cure for most patients.
Inflammation and cancer: Identifying the role of copper paves the way for new therapeutic applications

Inflammation and cancer: Identifying the role of copper paves the way for new therapeutic applications

byCNRSCD44 mediates copper uptake.a, Experimental setup used to generate inflammatory monocyte-derived macrophages (MDMs).b, Flow cytometry of CD44 in MDMs. Data are representative o

Inflammation and cancer: Identifying the role of copper paves the way for new therapeutic applications

byCNRSCD44 mediates copper uptake.a, Experimental setup used to generate inflammatory monocyte-derived macrophages (MDMs).b, Flow cytometry of CD44 in MDMs. Data are representative o
MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway

MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway

by Impact Journals LLCEvaluation of the toxicity of MK256 in vivo. Credit:Oncotarget(2022). DOI: 10.18632/oncotarget.28305A new research paper titled "MK256 is a novel CDK8 inhibitor

MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway

by Impact Journals LLCEvaluation of the toxicity of MK256 in vivo. Credit:Oncotarget(2022). DOI: 10.18632/oncotarget.28305A new research paper titled "MK256 is a novel CDK8 inhibitor
New blood test revolutionizes early cancer detection in Li-Fraumeni Syndrome patients

New blood test revolutionizes early cancer detection in Li-Fraumeni Syndrome patients

In a study published inCancer Discovery, researchers from Canada tested the use of a multimodal liquid biopsy assay based on cell-free DNA (cfDNA) for early cancer detection in patients with Li-

New blood test revolutionizes early cancer detection in Li-Fraumeni Syndrome patients

In a study published inCancer Discovery, researchers from Canada tested the use of a multimodal liquid biopsy assay based on cell-free DNA (cfDNA) for early cancer detection in patients with Li-
Novel combination of antibodies leads to significant improvement in cancer immunotherapy

Novel combination of antibodies leads to significant improvement in cancer immunotherapy

byUniversity of BaselCredit: CC0 Public DomainThe simultaneous use of antibodies based on two differing mechanisms of action leads to a more effective destruction of tumors. This has been demons

Novel combination of antibodies leads to significant improvement in cancer immunotherapy

byUniversity of BaselCredit: CC0 Public DomainThe simultaneous use of antibodies based on two differing mechanisms of action leads to a more effective destruction of tumors. This has been demons
Colorectal cancer initiation and progression: the role of low oxygen

Colorectal cancer initiation and progression: the role of low oxygen

byUniversity of LuxembourgScientists from the University of Luxembourg together with researchers from the Integrated Biobank of Luxembourg (IBBL) and the Luxembourg Institute of Health (LIH) hav

Colorectal cancer initiation and progression: the role of low oxygen

byUniversity of LuxembourgScientists from the University of Luxembourg together with researchers from the Integrated Biobank of Luxembourg (IBBL) and the Luxembourg Institute of Health (LIH) hav
Scientists learn what women know—and don't know—about breast density and cancer risk

Scientists learn what women know—and don't know—about breast density and cancer risk

byDartmouth-Hitchcock Medical CenterMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainBreast density is an important risk factor for breast cancer

Scientists learn what women know—and don't know—about breast density and cancer risk

byDartmouth-Hitchcock Medical CenterMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainBreast density is an important risk factor for breast cancer
Adjuvant Nivolumab Receives CHMP Recommendation for Completely Resected Stage IIB/C Melanoma

Adjuvant Nivolumab Receives CHMP Recommendation for Completely Resected Stage IIB/C Melanoma

July 21, 2023Chris RyanThe European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended approval of nivolumab monotherapy for the adjuvant treatment of patients at least

Adjuvant Nivolumab Receives CHMP Recommendation for Completely Resected Stage IIB/C Melanoma

July 21, 2023Chris RyanThe European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended approval of nivolumab monotherapy for the adjuvant treatment of patients at least
New way to determine whether metastatic cancer cells in breast cancer patients are dormant or soon to turn deadly

New way to determine whether metastatic cancer cells in breast cancer patients are dormant or soon to turn deadly

byThe Mount Sinai HospitalFor the first time ever, Mount Sinai researchers have identified a protein as a marker that can indicate whether a cancer patient will develop a reoccurrence of lethal,

New way to determine whether metastatic cancer cells in breast cancer patients are dormant or soon to turn deadly

byThe Mount Sinai HospitalFor the first time ever, Mount Sinai researchers have identified a protein as a marker that can indicate whether a cancer patient will develop a reoccurrence of lethal,
Researchers develop priorities for interventions to address health disparities in lung nodule management

Researchers develop priorities for interventions to address health disparities in lung nodule management

by Boston University School of MedicineCascade-of-care framework for identifying potential areas for intervention to reduce disparities in lung nodule evaluation. This figure shows each step of a

Researchers develop priorities for interventions to address health disparities in lung nodule management

by Boston University School of MedicineCascade-of-care framework for identifying potential areas for intervention to reduce disparities in lung nodule evaluation. This figure shows each step of a
Stop marginalising men with breast cancer

Stop marginalising men with breast cancer

by Kerry Quincey,The ConversationCredit: AI-generated imageBreast cancer is the most common cancer in theUKand the leading cancerin women worldwide. Approximately 150 cases are

Stop marginalising men with breast cancer

by Kerry Quincey,The ConversationCredit: AI-generated imageBreast cancer is the most common cancer in theUKand the leading cancerin women worldwide. Approximately 150 cases are
Integrating mental health services into oncology treatment protocols

Integrating mental health services into oncology treatment protocols

byThe City University of New YorkStudy participant is interviewed. Credit: The City University of New YorkA new study by CUNY SPH doctoral student Thinh Vu and colleagues reveals that cancer inp

Integrating mental health services into oncology treatment protocols

byThe City University of New YorkStudy participant is interviewed. Credit: The City University of New YorkA new study by CUNY SPH doctoral student Thinh Vu and colleagues reveals that cancer inp